Fleet Bioprocessing has announced that it will be attending the European Bioanalytical Forum (EBF) 11th Open Symposium.
Taking place from 21–23 November, EBF aims to bring companies together to implement a platform for discussions of science, day-to-day procedures, business tools, technologies and regulatory issues.
Fleet Bioprocessing will be offering expertise in the development, validation and manufacture of bioconjugates. It also possesses industry-leading expertise in all aspects of immunoassay design, development and validation and is a certified assay transfer and development partner for the Gyrolab high-throughput immunoassay platform.
If you would like to discuss any aspect of bioconjugation, enzyme-linked immunosorbent assay (ELISA) development or Gyrolab assay development, please contact Fleet Bioprocessing using the contact form on this page.